Urge Incontinence

Urge incontinence, sometimes referred to as overactive bladder is the sudden need to urinate. Urge incontinence can sometimes lead to urine leak which affects the quality of life. There are several treatments among which anticholinergics administration is the most popular one. Mirabegron, alpha blockers or topical estrogen are also some of the options.

Parkinson's disease is caused by a loss of nerve cells in part of the brain called the substantia nigra. A person with Parkinson's disease can also experience a wide range of other physical symptoms. Constipation is one of the most commonly reported physical symptoms of Parkinson's disease. Accordin...

The major trends that defines the Urinary Incontinence market over the analysis timeframe are stated in the report, along with additional pointers such as industry policies and regional industry layout. Other information included in the Urinary Incontinence market report is advantages and disadvanta...

The reality is this: facing urinary incontinence and suffering in silence can impact a woman's quality of life. TYPES OF URINARY INCONTINENCE. Stress urinary incontinence is loss of urine with activities like sneezing, walking, coughing or jumping, whereas urgency urinary incontinence is loss of uri...

Continuing to play virtually, the Spectrum Festival on May 1 to 3 includes the Peruvian film, "Retablo," a fictional story about a teenaged boy who discovers upsetting news about his father's sexual orientation. Fourteen-year-old Segundo works with his father, Noé, to make painted shadow b...

The size of the adult incontinence product market, which is projected to hit $28.7 billion by 2025 on a global basis, shows that permanent solutions are few and far between. Kimberley Clark has gone into production overdrive to meet the demand for their incontinence and essential products. The devel...

On the basis of End User, the Global Urinary Incontinence Device Market is studied across Clinics and Hospitals. Market Penetration: Provides comprehensive information on sulfuric acid offered by the key players in the Global Urinary Incontinence Device Market 2. Market Development: Provides in-dept...

Vibegron, an oral small molecule beta-3 agonist currently under FDA review for overactive bladder treatment, provides favorable efficacy and safety over 52 weeks, researchers announced during the American Urological Association 2020 Virtual Experience. In a 40-week extension of the 12-week phase 3 E...

It's often thought of as an older woman's problem but in fact, more than one million Australian men are living with urinary or faecal incontinence today. Still, men are often uninformed about the issues, and those with it are often too embarrassed to seek treatment. Starts at 60 spoke to the Contine...

The Food and Drug Administration has approved a new version of Axonics Modulation's rechargeable implantable sacral neurostimulator system that allows patients to decrease the frequency of charging to once a month. The first iteration of the device was approved by the FDA late last year. Axonics r-S...

Submit Post

By posting to this website and replying to posts you agree to these rules.